Amanote Research

Amanote Research

    RegisterSign In

Safety, Tolerability and Risk Benefit Analysis of Tiotropium in COPD

International Journal of COPD - New Zealand
doi 10.2147/copd.s3530
Full Text
Open PDF
Abstract

Available in full text

Categories
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
Date

December 1, 2008

Authors
Yuji Oba
Publisher

Informa UK Limited


Related search

Explaining Differential Effects of Tiotropium on Mortality in COPD

Thorax
PulmonaryRespiratory Medicine
2013English

A Risk-Based Approach to Cost-Benefit Analysis of Software Safety Activities

English

Ibuprofen Versus Steroids: Risk and Benefit, Efficacy and Safety

Pediatria Medica e Chirurgica
Child HealthSurgeryPediatricsPerinatology
2013English

Safety and Risk—Benefit Profile of Microbubble Contrast Agents in Echocardiography

Asia Pacific Cardiology
2008English

Tolerability of Bisoprolol on Domiciliary Spirometry in COPD

Lung
PulmonaryRespiratory Medicine
2017English

Effects of Tiotropium and Formoterol on Dynamic Hyperinflation and Exercise Endurance in COPD

Respiratory Medicine
PulmonaryRespiratory Medicine
2010English

Efficacy and Safety Profile of Xanthines in COPD: A Network Meta-Analysis

European Respiratory Review
PulmonaryRespiratory Medicine
2018English

Unbalanced Risk-Benefit Analysis of ADHD Drugs

The Lancet Psychiatry
PsychiatryBiological PsychiatryMental Health
2018English

PND3 Risk-Benefit Analysis of Therapy in Multiple Sclerosis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy